[go: up one dir, main page]

PL322134A1 - Trisubstituted phenyl derivatives - Google Patents

Trisubstituted phenyl derivatives

Info

Publication number
PL322134A1
PL322134A1 PL96322134A PL32213496A PL322134A1 PL 322134 A1 PL322134 A1 PL 322134A1 PL 96322134 A PL96322134 A PL 96322134A PL 32213496 A PL32213496 A PL 32213496A PL 322134 A1 PL322134 A1 PL 322134A1
Authority
PL
Poland
Prior art keywords
pct
phenyl derivatives
trisubstituted phenyl
date sep
sec
Prior art date
Application number
PL96322134A
Other versions
PL185875B1 (en
Inventor
Peter Nussbaumer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9505080.3A external-priority patent/GB9505080D0/en
Priority claimed from GBGB9505858.2A external-priority patent/GB9505858D0/en
Priority claimed from GBGB9526593.0A external-priority patent/GB9526593D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PL322134A1 publication Critical patent/PL322134A1/en
Publication of PL185875B1 publication Critical patent/PL185875B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PCT No. PCT/EP96/01116 Sec. 371 Date Sep. 15, 1997 Sec. 102(e) Date Sep. 15, 1997 PCT Filed Mar. 14, 1996 PCT Pub. No. WO96/28430 PCT Pub. Date Sep. 19, 1996The invention concerns compounds of formula I wherein the substituents have various meanings, and their use in the prevention or treatment of inflammatory and proliferative skin diseases and cancer.
PL96322134A 1995-03-14 1996-03-14 Trisubstituted phenyl derivatives PL185875B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9505080.3A GB9505080D0 (en) 1995-03-14 1995-03-14 Organic compounds
GBGB9505858.2A GB9505858D0 (en) 1995-03-23 1995-03-23 Organic Compounds
GBGB9526593.0A GB9526593D0 (en) 1995-12-28 1995-12-28 Organic compounds
PCT/EP1996/001116 WO1996028430A1 (en) 1995-03-14 1996-03-14 Trisubstituted phenyl derivatives

Publications (2)

Publication Number Publication Date
PL322134A1 true PL322134A1 (en) 1998-01-05
PL185875B1 PL185875B1 (en) 2003-08-29

Family

ID=27267624

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96322134A PL185875B1 (en) 1995-03-14 1996-03-14 Trisubstituted phenyl derivatives

Country Status (23)

Country Link
US (1) US5990116A (en)
EP (1) EP0815087B1 (en)
JP (1) JP3194963B2 (en)
KR (1) KR100437580B1 (en)
CN (1) CN1101386C (en)
AT (1) ATE208763T1 (en)
AU (1) AU704544B2 (en)
BR (1) BR9607240A (en)
CA (1) CA2214131C (en)
CZ (1) CZ289944B6 (en)
DE (1) DE69616993T2 (en)
DK (1) DK0815087T3 (en)
ES (1) ES2168463T3 (en)
FI (1) FI120537B (en)
HU (1) HUP9801828A3 (en)
MX (1) MX9707022A (en)
NO (1) NO310356B1 (en)
NZ (1) NZ304291A (en)
PL (1) PL185875B1 (en)
PT (1) PT815087E (en)
RU (1) RU2164224C2 (en)
SK (1) SK282155B6 (en)
WO (1) WO1996028430A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747498A (en) 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US6706721B1 (en) 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
JP3270834B2 (en) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク Heteroaromatic bicyclic derivatives useful as anticancer agents
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
UA74803C2 (en) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. A stable polymorph of n-(3-ethynylphenyl)-6,7-bis(2-methoxyetoxy)-4-quinazolinamine hydrochloride, a method for producing thereof (variants) and pharmaceutical use
US7087613B2 (en) 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
JP4665331B2 (en) * 2000-04-07 2011-04-06 チッソ株式会社 Novel diamino compound, polymer synthesized using the diamino compound, and varnish, alignment film and liquid crystal display element using the polymer
JP4164028B2 (en) * 2001-10-12 2008-10-08 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Alkyne matrix metalloproteinase inhibitors
US7053216B2 (en) 2001-11-19 2006-05-30 Iconix Pharmaceuticals, Inc. Modulators of Rho C activity
WO2003097053A1 (en) 2002-05-09 2003-11-27 Cytokinetics, Inc. Compounds, compositions, and methods
WO2003103575A2 (en) 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
JP2006502991A (en) * 2002-07-17 2006-01-26 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー Combinations of allosteric alkyne inhibitors of matrix metalloproteinase-13 and selective inhibitors of cyclooxygenase-2 that are not celecoxib or valdecoxib
JP2006502114A (en) * 2002-07-17 2006-01-19 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー Combination of matrix metalloproteinase-13 allosteric alkyne inhibitors with celecoxib or valdecoxib
AU2003256805A1 (en) 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
AU2003249539A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
AU2003277079A1 (en) 2002-09-30 2004-05-04 Cytokinetics, Inc. Compounds, compositions, and methods
ES2270154T3 (en) * 2002-12-13 2007-04-01 F. Hoffmann-La Roche Ag DERIVATIVES OF 3H-QUINAZOLIN-4-ONA.
GB0319497D0 (en) * 2003-08-19 2003-09-17 Novartis Ag Organic compounds
SE0400234D0 (en) * 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
JP2007528393A (en) * 2004-03-11 2007-10-11 カイセラ バイオファーマシューティカルズ， インコーポレイテッド Compositions and methods for preventing and treating skin conditions and hair conditions
US20080031898A1 (en) * 2004-03-26 2008-02-07 David Nathaniel E Compositions and methods to increase the effect of a neurotoxin treatment
GB0412769D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
IL180887A (en) * 2004-08-04 2014-04-30 Nippon Kayaku Kk Quinoline derivatives and insecticides comprising them as active ingredient
WO2008044688A1 (en) * 2006-10-11 2008-04-17 Daiichi Sankyo Company, Limited Urea derivative
CA2677457A1 (en) * 2007-02-06 2008-08-14 Helen Tuvesson Andersson New compounds, methods for their preparation and use thereof
US20210017174A1 (en) 2018-03-07 2021-01-21 Bayer Aktiengesellschaft Identification and use of erk5 inhibitor
WO2021026672A1 (en) * 2019-08-09 2021-02-18 Novartis Ag Heterocyclic wdr5 inhibitors as anti-cancer compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028305B1 (en) * 1979-09-13 1984-02-01 The Wellcome Foundation Limited Diaryl compounds and pharmaceutical formulations containing them
CA1219587A (en) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
NO174506B (en) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogous procedure for the preparation of therapeutically active compounds
CH661687A5 (en) * 1984-12-19 1987-08-14 Battelle Memorial Institute NEEDLE MATRIX PRINTER.
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
WO1988003806A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
KR890700023A (en) * 1986-11-19 1989-03-02 케맥스 파마슈우티칼스 인코포레이티드 Lipoxygenase inhibitors
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US5272167A (en) * 1986-12-10 1993-12-21 Schering Corporation Pharmaceutically active compounds
KR920701167A (en) * 1989-07-07 1992-08-11 에릭 에스. 딕커 Pharmaceutically active compounds
RU2025473C1 (en) * 1990-07-27 1994-12-30 Исихара Сангио Кайся Лтд. Benzoylurea derivatives or pharmaceutically acceptable salts thereof having antitumor activity
HUT60458A (en) * 1991-02-01 1992-09-28 Sandoz Ag Process for producing benzyloxyphenyl derivatives and pharmaceutical compositions comprising same
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
ES2108120T3 (en) * 1991-05-10 1997-12-16 Rhone Poulenc Rorer Int MONO- AND BICYCLE BIS ARYLIC AND HETEROARILIC COMPOUNDS INHIBITING EGF AND / OR PDGF TYPHOSINE KINASE.
GB9121943D0 (en) * 1991-10-16 1991-11-27 Sandoz Ltd Organic compounds,processes for their production and their use
US5656643A (en) * 1993-11-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Also Published As

Publication number Publication date
RU2164224C2 (en) 2001-03-20
HUP9801828A2 (en) 1999-03-29
DE69616993T2 (en) 2002-07-04
NO974118L (en) 1997-09-08
FI973440A0 (en) 1997-08-21
HUP9801828A3 (en) 2001-02-28
MX9707022A (en) 1998-06-30
SK124597A3 (en) 1998-01-14
AU704544B2 (en) 1999-04-29
CN1101386C (en) 2003-02-12
DE69616993D1 (en) 2001-12-20
US5990116A (en) 1999-11-23
WO1996028430A1 (en) 1996-09-19
NO310356B1 (en) 2001-06-25
NO974118D0 (en) 1997-09-08
ES2168463T3 (en) 2002-06-16
HK1014440A1 (en) 1999-09-30
KR19980703049A (en) 1998-09-05
EP0815087B1 (en) 2001-11-14
KR100437580B1 (en) 2004-07-16
CN1183774A (en) 1998-06-03
AU5144396A (en) 1996-10-02
PT815087E (en) 2002-04-29
PL185875B1 (en) 2003-08-29
FI120537B (en) 2009-11-30
CA2214131A1 (en) 1996-09-19
JP3194963B2 (en) 2001-08-06
SK282155B6 (en) 2001-11-06
NZ304291A (en) 1999-01-28
DK0815087T3 (en) 2002-03-11
EP0815087A1 (en) 1998-01-07
CZ286997A3 (en) 1997-12-17
CA2214131C (en) 2009-06-23
CZ289944B6 (en) 2002-04-17
JPH11503412A (en) 1999-03-26
FI973440L (en) 1997-10-24
ATE208763T1 (en) 2001-11-15
BR9607240A (en) 1997-11-11

Similar Documents

Publication Publication Date Title
PL322134A1 (en) Trisubstituted phenyl derivatives
IL132608A0 (en) Fused dihydropyran compounds medicaments containing the same and the use thereof
BG105270A (en) Tetrahydropyridoethers
IL110031A0 (en) Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
KR960701051A (en) IMIDAZOPYRIDINES AND THEIR USE IN TREATING CASTROINTESTINAL DISEASES
NO307027B1 (en) Use of riluzole in the treatment of neurological lesions related to traumatic injuries
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
MY135559A (en) Acylated aminoalkanimidazoles and - triazoles
ES2094545T3 (en) N-SUBSTITUTED DERIVATIVES OF 3-AZABICICLO (3.2.0) HEPTANE, LIKE NEUROLEPTICOS ETC ..
IL139144A0 (en) Mycobacterial inhibitors
NZ331165A (en) Verotoxin pharmaceutical compositions and medical treatments therewith
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
ATA57894A (en) AGENT FOR TREATING OSTEOPOROSIS
PL309339A1 (en) Novel triazoquinazolines, methods of obtaining them and their application
PT751774E (en) MERCAPTOACETILAMIDE DISSULFURET DERIVATIVES HYPOCOLSTEROLEMICS
MY116727A (en) Tetrahydropyrido compounds
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110314